I agree, it seems very strange, almost as if a second tier of investigation was layered over the original research project - that of effectiveness of prescribed opioids in non-cancer pain.
If one was to investigate 'use of cannabis', one would think standard measures of drug use: formulation, dosage, method of administration etc. would be integral to the study.
Seems their only measure was dosage - itself categorised into "not", "less frequent" and "daily or near daily", which is pretty weak imho . We are left to assume how these unquantifiable doses were administered to participants.
Clearly this was not a clinical trial, yet it leans toward clinical trial outcomes measures. Odd. Stewart was right to point out the value a clinical study can have.
imho, this paper adds little to the literature on therapeutic effectiveness of cannabis.
- Forums
- ASX - By Stock
- AC8
- Canabis has no benefit for chronic pain
Canabis has no benefit for chronic pain, page-15
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable